R. Maréchaud

2.1k total citations
74 papers, 1.4k citations indexed

About

R. Maréchaud is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, R. Maréchaud has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 14 papers in Genetics. Recurrent topics in R. Maréchaud's work include Thyroid Cancer Diagnosis and Treatment (12 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (9 papers). R. Maréchaud is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (12 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (9 papers). R. Maréchaud collaborates with scholars based in France, Australia and Poland. R. Maréchaud's co-authors include Samy Hadjadj, F. Torremocha, J.L. Kraimps, Stéphanie Ragot, J Barbier, B Charbonnel, D Herpin, P. Sosner, Pierre Lecomte and Lucy Chaillous and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

R. Maréchaud

71 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Maréchaud France 19 971 567 333 213 147 74 1.4k
Ramazan Sarı Türkiye 19 496 0.5× 391 0.7× 128 0.4× 131 0.6× 186 1.3× 102 1.3k
Jordi Mesa Spain 19 669 0.7× 267 0.5× 191 0.6× 90 0.4× 286 1.9× 86 1.4k
Jacob E. Poulsen Denmark 14 911 0.9× 604 1.1× 832 2.5× 144 0.7× 108 0.7× 25 1.8k
Barış Akıncı Türkiye 26 730 0.8× 480 0.8× 250 0.8× 151 0.7× 212 1.4× 128 1.9k
Levent Kebapçılar Türkiye 22 405 0.4× 324 0.6× 79 0.2× 115 0.5× 129 0.9× 94 1.2k
Sandra Brogioni Italy 25 1.4k 1.4× 207 0.4× 85 0.3× 240 1.1× 145 1.0× 43 1.8k
L Madácsy Hungary 18 427 0.4× 622 1.1× 587 1.8× 85 0.4× 111 0.8× 106 1.3k
W. Timmermann Germany 18 256 0.3× 1.3k 2.3× 64 0.2× 90 0.4× 122 0.8× 102 1.7k
Stefano Spiezia Italy 24 2.1k 2.2× 1.2k 2.1× 87 0.3× 236 1.1× 219 1.5× 44 2.4k
Francesco Boi Italy 21 796 0.8× 430 0.8× 98 0.3× 35 0.2× 168 1.1× 41 1.1k

Countries citing papers authored by R. Maréchaud

Since Specialization
Citations

This map shows the geographic impact of R. Maréchaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Maréchaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Maréchaud more than expected).

Fields of papers citing papers by R. Maréchaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Maréchaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Maréchaud. The network helps show where R. Maréchaud may publish in the future.

Co-authorship network of co-authors of R. Maréchaud

This figure shows the co-authorship network connecting the top 25 collaborators of R. Maréchaud. A scholar is included among the top collaborators of R. Maréchaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Maréchaud. R. Maréchaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leveziel, Nicolas, Stéphanie Ragot, Elise Gand, et al.. (2015). Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients. Medicine. 94(33). e1220–e1220. 8 indexed citations
2.
Sosner, P., Pierre‐Jean Saulnier, Séverin Cabasson, et al.. (2014). Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage. American Heart Journal. 169(1). 108–114.e7. 6 indexed citations
3.
Gautier, J.F., et al.. (2010). Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complications. Annales d Endocrinologie. 71(6). 505–510. 2 indexed citations
4.
Riveline, Jean‐Pierre, Sylvia Franc, Dured Dardari, et al.. (2009). Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrology Dialysis Transplantation. 24(9). 2866–2871. 99 indexed citations
5.
Hadjadj, Samy, Stéphanie Ragot, C. Millet, et al.. (2007). Diagnostic strategy for growth hormone deficiency: relevance of IGF-1 determination as a screening test. Annales d Endocrinologie. 68(6). 449–455. 7 indexed citations
6.
Torremocha, F., et al.. (2006). Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy. Diabetes & Metabolism. 32(4). 358–363. 3 indexed citations
7.
Maréchaud, R.. (2005). Polyendocrinopathies auto-immunes. Annales d Endocrinologie. 66(1). 77–79. 3 indexed citations
8.
Hadjadj, Samy, D Coisne, Gérard Mauco, et al.. (2004). Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabetic Medicine. 21(4). 305–310. 121 indexed citations
9.
Caron, Philippe, S Arlot, Catherine Bauters, et al.. (2001). Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 86(6). 2849–2853. 68 indexed citations
10.
Paccalin, Marc, D. Gouet, Vincent Delwail, et al.. (2001). Lymphome malin primitif de la thyroïde : à propos de huit cas. La Revue de Médecine Interne. 22(10). 934–938. 1 indexed citations
11.
Chaillous, Lucy, Hervé Lefèvre, Charles Thivolet, et al.. (2000). Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. The Lancet. 356(9229). 545–549. 189 indexed citations
12.
Chaillous, Lucy, V. Rohmer, D Maugendre, et al.. (1996). Differential β-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus. Metabolism. 45(3). 306–314. 20 indexed citations
13.
Bardet, Stéphane, V. Rohmer, Arnaud Murat, et al.. (1996). 131I‐6β‐Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology. 44(5). 587–596. 55 indexed citations
14.
Roblot, P., et al.. (1994). Primum non nocere. Étude prospective de 115 observations de pathologies iatrogènes recueillies en 1 an chez 106 malades. La Revue de Médecine Interne. 15(11). 720–726. 7 indexed citations
15.
Roblot, P., F. Roblot, Jean‐Louis Fauchere, et al.. (1994). Retrospective study of 108 cases of botulism in Poitiers, France. Journal of Medical Microbiology. 40(6). 379–384. 29 indexed citations
16.
Roblot, P., et al.. (1993). Pertes de connaissance brèves dans un service de Médecine Interne. Étude du bilan initial et du devenir à moyen terme. La Revue de Médecine Interne. 14(3). 189–193. 1 indexed citations
17.
Roblot, P., et al.. (1993). Primum non nocere, un adage parfois oublié. À propos de 106 observations de pathologies iatrogènes recueillies en un an. La Revue de Médecine Interne. 14(10). 950–950. 2 indexed citations
18.
Arnaud, A., et al.. (1992). Toxicité neurologique de l'amiodarone. À propos de cinq observations. La Revue de Médecine Interne. 13(6). 419–422. 12 indexed citations
19.
Maréchaud, R., J C Rambaud, & Claude Matuchansky. (1980). Manifestations intestinales des affections thyroïdiennes. Aspects cliniques et physiopathologiques actuels.. Gastroentérologie Clinique et Biologique. 4(12). 899–910. 2 indexed citations
20.
Becq-Giraudon, B, et al.. (1979). Hypercalcémie paranéoplasique au cours d'un cancer de la vessie. Mise en évidence dans la tumeur d'une substance à activité parathormone.. ˜La œNouvelle presse médicale. 8(16). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramazan Sarı Breakdown of academic impact, for papers by Jordi Mesa Breakdown of academic impact, for papers by Jacob E. Poulsen Breakdown of academic impact, for papers by Barış Akıncı Breakdown of academic impact, for papers by Levent Kebapçılar Breakdown of academic impact, for papers by Sandra Brogioni Breakdown of academic impact, for papers by L Madácsy Breakdown of academic impact, for papers by W. Timmermann Breakdown of academic impact, for papers by Stefano Spiezia Breakdown of academic impact, for papers by Francesco Boi
Rankless by CCL
2026